Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Lu, Chengxing"" wg kryterium: Autor


Tytuł :
Methods for detecting functional classifications in neuroimaging data.
Autorzy :
Bowman FD; Department of Biostatistics, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, USA. />Patel R
Lu C
Pokaż więcej
Źródło :
Human brain mapping [Hum Brain Mapp] 2004 Oct; Vol. 23 (2), pp. 109-19.
Typ publikacji :
Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Algorithms*
Cluster Analysis*
Positron-Emission Tomography*
Brain/*physiology
Brain Mapping/*methods
Brain/diagnostic imaging ; Humans ; Radiography ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
Liver enzymes elevation and immune reconstitution among treatment-naïve HIV-infected patients instituting antiretroviral therapy.
Autorzy :
Ofotokun I; Division of Infectious Disease, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30303, USA. />Smithson SE
Lu C
Easley KA
Lennox JL
Pokaż więcej
Źródło :
The American journal of the medical sciences [Am J Med Sci] 2007 Nov; Vol. 334 (5), pp. 334-41.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Alanine Transaminase/*blood
Anti-Retroviral Agents/*adverse effects
Aspartate Aminotransferases/*blood
HIV Infections/*drug therapy
Immune Reconstitution Inflammatory Syndrome/*chemically induced
Adult ; Alkynes ; Anti-HIV Agents/adverse effects ; Anti-HIV Agents/therapeutic use ; Anti-Retroviral Agents/therapeutic use ; Benzoxazines/adverse effects ; CD4-Positive T-Lymphocytes/pathology ; Cyclopropanes ; Drug Therapy, Combination ; Female ; HIV Infections/blood ; HIV Infections/complications ; HIV Infections/enzymology ; Hepatitis B/blood ; Hepatitis B/complications ; Hepatitis B/pathology ; Hepatitis C/blood ; Hepatitis C/complications ; Hepatitis C/pathology ; Humans ; Immune Reconstitution Inflammatory Syndrome/blood ; Immune Reconstitution Inflammatory Syndrome/pathology ; Lamivudine/adverse effects ; Lamivudine/therapeutic use ; Linear Models ; Male ; Middle Aged ; Multivariate Analysis ; Retrospective Studies ; Risk Factors ; Stavudine/adverse effects ; Stavudine/therapeutic use ; Zidovudine/adverse effects ; Zidovudine/therapeutic use
Czasopismo naukowe
Tytuł :
Does screening in the emergency department hurt or help victims of intimate partner violence?
Autorzy :
Houry D; Department of Emergency Medicine, Emory University, Atlanta, GA 30303, USA. />Kaslow NJ
Kemball RS
McNutt LA
Cerulli C
Straus H
Rosenberg E
Lu C
Rhodes KV
Pokaż więcej
Źródło :
Annals of emergency medicine [Ann Emerg Med] 2008 Apr; Vol. 51 (4), pp. 433-42, 442.e1-7. Date of Electronic Publication: 2008 Mar 07.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Mass Screening*
Domestic Violence/*prevention & control
Emergency Service, Hospital/*organization & administration
Adolescent ; Adult ; Computers ; Female ; Humans ; Interviews as Topic ; Male ; Middle Aged ; Prospective Studies ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Prevalence of Down syndrome among children and adolescents in 10 regions of the United States.
Autorzy :
Shin M; Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. />Besser LM
Kucik JE
Lu C
Siffel C
Correa A
Pokaż więcej
Corporate Authors :
Congenital Anomaly Multistate Prevalence and Survival Collaborative
Źródło :
Pediatrics [Pediatrics] 2009 Dec; Vol. 124 (6), pp. 1565-71.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Down Syndrome/*epidemiology
Adolescent ; Adult ; Child ; Child, Preschool ; Cross-Sectional Studies ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Maternal Age ; Population Surveillance ; Registries ; Risk Factors ; United States
Czasopismo naukowe
Tytuł :
Long-term survival of infants with atrioventricular septal defects.
Autorzy :
Miller A; Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA; Oak Ridge Institute for Science and Education, Atlanta, GA. Electronic address: .
Siffel C; Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA; Computer Sciences Corporation, Atlanta, GA.
Lu C; Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA; Merck Research Laboratories, Upper Gwynedd, PA.
Riehle-Colarusso T; Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA.
Frías JL; Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA; McKing Consulting Corporation, Fairfax, VA.
Correa A; Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA.
Pokaż więcej
Źródło :
The Journal of pediatrics [J Pediatr] 2010 Jun; Vol. 156 (6), pp. 994-1000. Date of Electronic Publication: 2010 Mar 15.
Typ publikacji :
Journal Article
MeSH Terms :
Down Syndrome/*epidemiology
Heart Septal Defects, Atrial/*mortality
Heart Septal Defects, Ventricular/*mortality
Comorbidity ; Down Syndrome/mortality ; Female ; Heart Septal Defects, Atrial/epidemiology ; Heart Septal Defects, Ventricular/epidemiology ; Humans ; Infant ; Kaplan-Meier Estimate ; Male ; Prognosis ; Proportional Hazards Models ; Risk Factors
Czasopismo naukowe
Tytuł :
Prevalence of spina bifida among children and adolescents in 10 regions in the United States.
Autorzy :
Shin M; Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. />Besser LM
Siffel C
Kucik JE
Shaw GM
Lu C
Correa A
Pokaż więcej
Corporate Authors :
Congenital Anomaly Multistate Prevalence and Survival Collaborative
Źródło :
Pediatrics [Pediatrics] 2010 Aug; Vol. 126 (2), pp. 274-9. Date of Electronic Publication: 2010 Jul 12.
Typ publikacji :
Journal Article
MeSH Terms :
Spinal Dysraphism/*epidemiology
Adolescent ; Catchment Area, Health ; Child ; Child, Preschool ; Congenital Abnormalities/epidemiology ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Prevalence ; Retrospective Studies ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Sustained efficacy and safety of raltegravir after 5 years of combination antiretroviral therapy as initial treatment of HIV-1 infection: final results of a randomized, controlled, phase II study (Protocol 004).
Autorzy :
Gotuzzo E; Department to de Enfermedades Infecciosas y Tropicales, Hospital Nacional Cayetano Heredia, Lima, Peru.
Markowitz M
Ratanasuwan W
Smith G
Prada G
Morales-Ramirez JO
Strohmaier KM
Lu C
Bhanja S
Nguyen BY
Teppler H
Pokaż więcej
Corporate Authors :
Protocol 004 Study Team
Źródło :
Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2012 Sep 01; Vol. 61 (1), pp. 73-7.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Retroviral Agents/*administration & dosage
Anti-Retroviral Agents/*adverse effects
HIV Infections/*drug therapy
HIV-1/*isolation & purification
Pyrrolidinones/*administration & dosage
Pyrrolidinones/*adverse effects
Adult ; Aged ; Antiretroviral Therapy, Highly Active/adverse effects ; Antiretroviral Therapy, Highly Active/methods ; CD4 Lymphocyte Count ; Double-Blind Method ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Female ; HIV Infections/virology ; Humans ; Male ; Middle Aged ; RNA, Viral/blood ; Raltegravir Potassium ; Treatment Outcome ; Viral Load
Czasopismo naukowe
Tytuł :
Sustained Efficacy and Safety of Raltegravir After 5 Years of Combination Antiretroviral Therapy as Initial Treatment of HIV-1 Infection.
Autorzy :
Gotuzzo, Eduardo
Markowitz, Martin
Ratanasuwan, Winai
Smith, Graham
Prada, Guillermo
Morales-Ramirez, Javier O.
Strohmaier, Kim M.
Lu, Chengxing
Bhanja, Sanhita
Nguyen, Bach-Yen
Teppler, Hedy
Pokaż więcej
Źródło :
JAIDS: Journal of Acquired Immune Deficiency Syndromes. 9/1/2012, Vol. 61 Issue 1, p73-77. 5p.
Czasopismo naukowe
Tytuł :
Safety, tolerability, and efficacy of raltegravir in a diverse cohort of HIV-infected patients: 48-week results from the REALMRK Study.
Autorzy :
Squires KE; Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA 19107, USA. />Bekker LG
Eron JJ
Cheng B
Rockstroh JK
Marquez F
Kumar P
Thompson M
Campo RE
Mounzer K
Strohmaier KM
Lu C
Rodgers A
Jackson BE
Wenning LA
Robertson M
Nguyen BY
Sklar P
Pokaż więcej
Corporate Authors :
REALMRK Investigators
Źródło :
AIDS research and human retroviruses [AIDS Res Hum Retroviruses] 2013 Jun; Vol. 29 (6), pp. 859-70. Date of Electronic Publication: 2013 Feb 26.
Typ publikacji :
Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
HIV Infections/*drug therapy
HIV Integrase Inhibitors/*therapeutic use
Pyrrolidinones/*therapeutic use
Adult ; Aged ; Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/therapeutic use ; Continental Population Groups ; Drug Resistance, Viral ; Drug Therapy, Combination ; Female ; HIV Integrase Inhibitors/administration & dosage ; HIV Integrase Inhibitors/adverse effects ; HIV Integrase Inhibitors/blood ; Humans ; Male ; Middle Aged ; Pyrrolidinones/administration & dosage ; Pyrrolidinones/adverse effects ; Pyrrolidinones/blood ; Raltegravir Potassium ; Sex Factors ; Treatment Outcome ; Viral Load/drug effects ; Young Adult
Czasopismo naukowe
Tytuł :
INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD.
Autorzy :
Rossi A; Pulmonary Unit, University of Verona, Verona, Italy .
van der Molen T; University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
del Olmo R; Fundación CIDEA and Hospital Maria Ferrer, Buenos Aires, Argentina.
Papi A; University of Ferrara, Ferrara, Italy.
Wehbe L; Fundacion Enfisema, Buenos Aires, Argentina.
Quinn M; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Lu C; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Young D; Novartis Horsham Research Centre, Horsham, UK.
Cameron R; Novartis Horsham Research Centre, Horsham, UK.
Bucchioni E; Novartis Farma, Origgio, Italy.
Altman P; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Pokaż więcej
Źródło :
The European respiratory journal [Eur Respir J] 2014 Dec; Vol. 44 (6), pp. 1548-56. Date of Electronic Publication: 2014 Oct 30.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Albuterol/*analogs & derivatives
Androstadienes/*therapeutic use
Bronchodilator Agents/*therapeutic use
Glucocorticoids/*therapeutic use
Indans/*therapeutic use
Pulmonary Disease, Chronic Obstructive/*drug therapy
Quinolones/*therapeutic use
Administration, Inhalation ; Aged ; Albuterol/therapeutic use ; Disease Progression ; Double-Blind Method ; Drug Combinations ; Drug Substitution ; Female ; Fluticasone-Salmeterol Drug Combination ; Forced Expiratory Volume ; Humans ; Male ; Middle Aged ; Severity of Illness Index ; Treatment Outcome ; Vital Capacity
Czasopismo naukowe
Tytuł :
Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials.
Autorzy :
Waldstein SM; Christian Doppler Laboratory for Ophthalmic Image Analysis, Vienna Reading Center, Department of Ophthalmology, Medical University of Vienna, Vienna, Austria.
Simader C; Christian Doppler Laboratory for Ophthalmic Image Analysis, Vienna Reading Center, Department of Ophthalmology, Medical University of Vienna, Vienna, Austria.
Staurenghi G; Eye Clinic, Department of Clinical Science 'Luigi Sacco'- Sacco Hospital, II School of Ophthalmology, University of Milan, Milan, Italy.
Chong NV; Oxford Eye Hospital, University of Oxford, Oxford, United Kingdom.
Mitchell P; Department of Ophthalmology, University of Sydney and Westmead Institute for Medical Research, Sydney, NSW, Australia.
Jaffe GJ; Duke Reading Center, Duke University, Durham, North Carolina.
Lu C; Bayer HealthCare, Whippany, New Jersey.
Katz TA; Bayer HealthCare, Whippany, New Jersey.
Schmidt-Erfurth U; Christian Doppler Laboratory for Ophthalmic Image Analysis, Vienna Reading Center, Department of Ophthalmology, Medical University of Vienna, Vienna, Austria. Electronic address: .
Pokaż więcej
Źródło :
Ophthalmology [Ophthalmology] 2016 Jul; Vol. 123 (7), pp. 1521-9. Date of Electronic Publication: 2016 May 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Angiogenesis Inhibitors/*therapeutic use
Ranibizumab/*therapeutic use
Receptors, Vascular Endothelial Growth Factor/*therapeutic use
Recombinant Fusion Proteins/*therapeutic use
Retina/*pathology
Visual Acuity/*drug effects
Wet Macular Degeneration/*drug therapy
Aged ; Aged, 80 and over ; Analysis of Variance ; Choroidal Neovascularization/drug therapy ; Female ; Humans ; Intravitreal Injections ; Male ; Middle Aged ; Prospective Studies ; Tomography, Optical Coherence ; Visual Acuity/physiology ; Wet Macular Degeneration/pathology ; Wet Macular Degeneration/physiopathology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies